<!DOCTYPE pdf2xml SYSTEM "pdf2xml.dtd">
<pdf2xml producer="poppler" version="23.04.0">
<page number="1" position="absolute" top="0" left="0" height="792" width="612">
	<fontspec id="font0" size="11" family="Helvetica-Black,Bold" color="#ffffff"/>
	<fontspec id="font1" size="8" family="AkzidenzGroteskBE,Bold" color="#000000"/>
	<fontspec id="font2" size="8" family="AkzidenzGroteskBE-Md,Bold" color="#000000"/>
	<fontspec id="font3" size="8" family="AkzidenzGroteskBE" color="#000000"/>
	<fontspec id="font4" size="8" family="Giovanni-Book" color="#000000"/>
	<fontspec id="font5" size="2" family="AkzidenzGroteskBE" color="#ffffff"/>
	<fontspec id="font6" size="15" family="AkzidenzGroteskBE" color="#000000"/>
	<fontspec id="font7" size="16" family="AkzidenzGroteskBE,BoldItalic" color="#000000"/>
	<fontspec id="font8" size="16" family="AkzidenzGroteskBE,Bold" color="#000000"/>
	<fontspec id="font9" size="12" family="AkzidenzGroteskBE" color="#000000"/>
	<fontspec id="font10" size="6" family="AkzidenzGroteskBE" color="#000000"/>
	<fontspec id="font11" size="8" family="AkzidenzGroteskBE-It,Italic" color="#000000"/>
	<fontspec id="font12" size="11" family="AkzidenzGroteskBE,Bold" color="#000000"/>
	<fontspec id="font13" size="9" family="AkzidenzGroteskBE-Md,Bold" color="#000000"/>
	<fontspec id="font14" size="9" family="AkzidenzGroteskBE" color="#000000"/>
	<fontspec id="font15" size="9" family="AkzidenzGroteskBE-It,Italic" color="#000000"/>
<text top="85" left="477" width="78" height="10" font="font0" id="p1_t1" reading_order_no="1" segment_no="1" tag_type="title">Open Access<a href="http://www.biomedcentral.com/info/about/charter/"><b>Open Access</b></a></text>
<text top="42" left="311" width="245" height="7" font="font1" id="p1_t2" reading_order_no="0" segment_no="0" tag_type="text">Available online http://breast-cancer-research.com/content/7/6/R987<b>Available online</b></text>
<text top="735" left="569" width="19" height="8" font="font4" id="p1_t3" reading_order_no="73" segment_no="27" tag_type="text">R987</text>
<text top="85" left="57" width="9" height="2" font="font5" id="p1_t4" reading_order_no="3" segment_no="2" tag_type="title">Vol 7 No 6</text>
<text top="85" left="57" width="103" height="14" font="font6" id="p1_t5" reading_order_no="2" segment_no="2" tag_type="title">Research article</text>
<text top="102" left="57" width="474" height="14" font="font7" id="p1_t6" reading_order_no="4" segment_no="3" tag_type="title">XRCC1 and XPD genetic polymorphisms, smoking and breast</text>
<text top="120" left="57" width="321" height="14" font="font8" id="p1_t7" reading_order_no="5" segment_no="3" tag_type="title">cancer risk in a Finnish case-control study<i><b>XRCC1 </b></i></text>
<text top="137" left="57" width="486" height="12" font="font9" id="p1_t8" reading_order_no="6" segment_no="4" tag_type="text">Katja Metsola 1 , Vesa Kataja 2 , Pia Sillanpää 1 , Päivi Siivola 1 , Liisa Heikinheimo 1 , Matti Eskelinen 3 ,<b>and </b></text>
<text top="153" left="57" width="275" height="12" font="font9" id="p1_t9" reading_order_no="7" segment_no="4" tag_type="text">Veli-Matti Kosma 4,5 , Matti Uusitupa 6 and Ari Hirvonen 1<i><b>XPD </b></i></text>
<text top="187" left="57" width="364" height="7" font="font3" id="p1_t10" reading_order_no="8" segment_no="5" tag_type="text">1 Department of Industrial Hygiene and Toxicology, Finnish Institute of Occupational Health, Helsinki, Finland<b>genetic polymorphisms, smoking and breast </b></text>
<text top="196" left="57" width="237" height="8" font="font3" id="p1_t11" reading_order_no="9" segment_no="6" tag_type="text">2 Department of Oncology, Kuopio University Hospital, Kuopio, Finland<b>cancer risk in a Finnish case-control study</b></text>
<text top="206" left="57" width="230" height="7" font="font3" id="p1_t12" reading_order_no="10" segment_no="7" tag_type="text">3 Department of Surgery, Kuopio University Hospital, Kuopio, Finland</text>
<text top="215" left="57" width="265" height="8" font="font3" id="p1_t13" reading_order_no="11" segment_no="8" tag_type="text">4 Department of Clinical Pathology, Kuopio University Hospital, Kuopio, Finland</text>
<text top="225" left="57" width="295" height="7" font="font3" id="p1_t14" reading_order_no="12" segment_no="9" tag_type="text">5 Department of Pathology and Forensic Medicine, University of Kuopio, Kuopio, Finland</text>
<text top="234" left="57" width="238" height="8" font="font3" id="p1_t15" reading_order_no="13" segment_no="10" tag_type="text">6 Department of Clinical Nutrition, University of Kuopio, Kuopio, Finland</text>
<text top="253" left="57" width="192" height="7" font="font3" id="p1_t16" reading_order_no="14" segment_no="11" tag_type="text">Corresponding author: Katja Metsola, katja.metsola@ttl.fi</text>
<text top="271" left="57" width="486" height="7" font="font3" id="p1_t17" reading_order_no="15" segment_no="12" tag_type="text">Received: 8 Jul 2005 Revisions requested: 11 Aug 2005 Revisions received: 6 Sep 2005 Accepted: 19 Sep 2005 Published: 11 Oct 2005</text>
<text top="289" left="57" width="243" height="7" font="font11" id="p1_t18" reading_order_no="16" segment_no="13" tag_type="text">Breast Cancer Research 2005, 7 :R987-R997 (DOI 10.1186/bcr1333)</text>
<text top="299" left="57" width="260" height="7" font="font3" id="p1_t19" reading_order_no="17" segment_no="14" tag_type="text">This article is online at: http://breast-cancer-research.com/content/7/6/R987</text>
<text top="309" left="57" width="180" height="7" font="font3" id="p1_t20" reading_order_no="18" segment_no="15" tag_type="text">© 2005 Metsola et al .; licensee BioMed Central Ltd.</text>
<text top="319" left="57" width="495" height="7" font="font3" id="p1_t21" reading_order_no="19" segment_no="16" tag_type="text">This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/</text>
<text top="329" left="57" width="426" height="7" font="font3" id="p1_t22" reading_order_no="20" segment_no="16" tag_type="text">2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</text>
<text top="359" left="57" width="43" height="10" font="font12" id="p1_t23" reading_order_no="21" segment_no="17" tag_type="title">Abstract</text>
<text top="379" left="57" width="240" height="8" font="font13" id="p1_t24" reading_order_no="22" segment_no="18" tag_type="text">Introduction It has been suggested that individuals with</text>
<text top="390" left="57" width="240" height="8" font="font14" id="p1_t25" reading_order_no="23" segment_no="18" tag_type="text">reduced DNA repair capacities might have increased</text>
<text top="400" left="57" width="240" height="8" font="font14" id="p1_t26" reading_order_no="24" segment_no="18" tag_type="text">susceptibility to environmentally induced cancer. In this study,</text>
<text top="411" left="57" width="240" height="8" font="font14" id="p1_t27" reading_order_no="25" segment_no="18" tag_type="text">we evaluated if polymorphisms in DNA repair genes XRCC1</text>
<text top="421" left="57" width="240" height="8" font="font14" id="p1_t28" reading_order_no="26" segment_no="18" tag_type="text">( Arg280His , Arg399Gln ) and XPD ( Lys751Gln ) modify</text>
<text top="432" left="57" width="240" height="8" font="font14" id="p1_t29" reading_order_no="27" segment_no="18" tag_type="text">individual breast cancer risk, with emphasis on tobacco</text>
<text top="442" left="57" width="34" height="8" font="font14" id="p1_t30" reading_order_no="28" segment_no="18" tag_type="text">smoking.</text>
<text top="463" left="57" width="240" height="8" font="font13" id="p1_t31" reading_order_no="29" segment_no="20" tag_type="text">Methods The study population consisted of 483 incident breast</text>
<text top="474" left="57" width="240" height="8" font="font14" id="p1_t32" reading_order_no="30" segment_no="20" tag_type="text">cancer cases and 482 population controls of Finnish Caucasian</text>
<text top="484" left="57" width="240" height="8" font="font14" id="p1_t33" reading_order_no="31" segment_no="20" tag_type="text">origin. The genotypes were determined by PCR-RFLP-based</text>
<text top="495" left="57" width="240" height="8" font="font14" id="p1_t34" reading_order_no="32" segment_no="20" tag_type="text">methods. Odds ratio (OR) and confidence intervals (CIs) were</text>
<text top="505" left="57" width="213" height="8" font="font14" id="p1_t35" reading_order_no="33" segment_no="20" tag_type="text">calculated by unconditional logistic regression analyses.</text>
<text top="526" left="57" width="240" height="8" font="font13" id="p1_t36" reading_order_no="34" segment_no="21" tag_type="text">Results No statistically significant overall effect in the breast</text>
<text top="537" left="57" width="240" height="8" font="font14" id="p1_t37" reading_order_no="35" segment_no="21" tag_type="text">cancer risk was seen for any of the studied polymorphisms.</text>
<text top="547" left="57" width="240" height="8" font="font14" id="p1_t38" reading_order_no="36" segment_no="21" tag_type="text">However, a significant increase in breast cancer risk was seen</text>
<text top="558" left="57" width="240" height="8" font="font14" id="p1_t39" reading_order_no="37" segment_no="21" tag_type="text">among ever smoking women if they carried at least one XRCC1-</text>
<text top="379" left="315" width="240" height="10" font="font15" id="p1_t40" reading_order_no="38" segment_no="19" tag_type="text">399 Gln allele (OR 2.33, 95% CI 1.30–4.19, p int 0.025) or XPD-</text>
<text top="390" left="315" width="240" height="18" font="font15" id="p1_t41" reading_order_no="39" segment_no="19" tag_type="text">751 Gln/Gln genotype (OR 2.52, 95% CI 1.27–5.03, p int 0.011) compared to smoking women not carrying these</text>
<text top="411" left="315" width="240" height="8" font="font14" id="p1_t42" reading_order_no="40" segment_no="19" tag_type="text">genotypes. The risks were found to be confined to women</text>
<text top="421" left="315" width="240" height="8" font="font14" id="p1_t43" reading_order_no="41" segment_no="19" tag_type="text">smoking at least five pack-years; the respective ORs were 4.14</text>
<text top="432" left="315" width="241" height="8" font="font14" id="p1_t44" reading_order_no="42" segment_no="19" tag_type="text">(95% CI 1.66–10.3) and 4.41 (95% CI 1.62–12.0). Moreover,</text>
<text top="442" left="315" width="240" height="8" font="font14" id="p1_t45" reading_order_no="43" segment_no="19" tag_type="text">a significant trend of increasing risk with increasing number of<i>Breast Cancer Research</i></text>
<text top="453" left="315" width="241" height="8" font="font14" id="p1_t46" reading_order_no="44" segment_no="19" tag_type="text">the putative at-risk genotypes ( p for trend 0.042) was seen.</text>
<text top="463" left="315" width="241" height="8" font="font14" id="p1_t47" reading_order_no="45" segment_no="19" tag_type="text">Women with at least two at-risk genotypes had an OR of 1.54<b>7</b></text>
<text top="474" left="315" width="240" height="8" font="font14" id="p1_t48" reading_order_no="46" segment_no="19" tag_type="text">(95% CI 1.00–2.41) compared to women with no at-risk</text>
<text top="484" left="315" width="241" height="8" font="font14" id="p1_t49" reading_order_no="47" segment_no="19" tag_type="text">genotypes. Even higher estimates were seen for ever actively<a href="http://breast-cancer-research.com/content/7/6/R987">This article is online at: http://breast-cancer-research.com/content/7/6/R987</a></text>
<text top="495" left="315" width="196" height="8" font="font14" id="p1_t50" reading_order_no="48" segment_no="19" tag_type="text">smoking women with at least two at-risk genotypes.</text>
<text top="526" left="315" width="240" height="8" font="font13" id="p1_t51" reading_order_no="49" segment_no="22" tag_type="text">Conclusion Our results do not indicate a major role for XRCC1<i> et al</i></text>
<text top="537" left="315" width="241" height="8" font="font14" id="p1_t52" reading_order_no="50" segment_no="22" tag_type="text">and XPD polymorphisms in breast cancer susceptibility, but</text>
<text top="547" left="315" width="240" height="8" font="font14" id="p1_t53" reading_order_no="51" segment_no="22" tag_type="text">suggest that they may modify the risk especially among smoking<a href="http://creativecommons.org/licenses/by/2.0"> (http://creativecommons.org/licenses/by/</a></text>
<text top="558" left="315" width="30" height="8" font="font14" id="p1_t54" reading_order_no="52" segment_no="22" tag_type="text">women.<a href="http://creativecommons.org/licenses/by/2.0">2.0),</a> which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</text>
<text top="611" left="57" width="64" height="10" font="font12" id="p1_t55" reading_order_no="53" segment_no="24" tag_type="title">Introduction<b>Abstract</b></text>
<text top="623" left="57" width="241" height="9" font="font14" id="p1_t56" reading_order_no="54" segment_no="25" tag_type="text">Breast cancer is the most common female cancer among<b>Introduction</b></text>
<text top="635" left="57" width="240" height="9" font="font14" id="p1_t57" reading_order_no="55" segment_no="25" tag_type="text">western societies and its incidence increases constantly. Hor-</text>
<text top="646" left="57" width="240" height="9" font="font14" id="p1_t58" reading_order_no="56" segment_no="25" tag_type="text">monal factors like early age at menarche, later age at meno-</text>
<text top="658" left="57" width="240" height="9" font="font14" id="p1_t59" reading_order_no="57" segment_no="25" tag_type="text">pause, later age at first full term pregnancy, and hormone</text>
<text top="670" left="57" width="240" height="9" font="font14" id="p1_t60" reading_order_no="58" segment_no="25" tag_type="text">replacement therapy are known to be the main risk factors for</text>
<text top="682" left="57" width="240" height="9" font="font14" id="p1_t61" reading_order_no="59" segment_no="25" tag_type="text">sporadic breast cancer [1,2]. Also, alcohol appears to contrib-<i>XRCC1</i></text>
<text top="693" left="57" width="240" height="9" font="font14" id="p1_t62" reading_order_no="60" segment_no="25" tag_type="text">ute to the increased risk for this malignancy, whereas the</text>
<text top="591" left="315" width="240" height="9" font="font14" id="p1_t63" reading_order_no="61" segment_no="23" tag_type="text">results concerning smoking are inconsistent [3-6]. The incon-<i>Arg280His</i></text>
<text top="603" left="315" width="240" height="9" font="font14" id="p1_t64" reading_order_no="62" segment_no="23" tag_type="text">sistencies might be due to several factors. For instance, ciga-</text>
<text top="615" left="315" width="240" height="9" font="font14" id="p1_t65" reading_order_no="63" segment_no="23" tag_type="text">rette smoke increases the production of reactive oxygen<i>Arg399Gln</i></text>
<text top="627" left="315" width="240" height="9" font="font14" id="p1_t66" reading_order_no="64" segment_no="23" tag_type="text">species (ROS) and contains chemical carcinogens capable of</text>
<text top="638" left="315" width="240" height="9" font="font14" id="p1_t67" reading_order_no="65" segment_no="23" tag_type="text">forming DNA adducts [7], both implicated in carcinogenesis.<i>XPD </i></text>
<text top="650" left="315" width="240" height="9" font="font14" id="p1_t68" reading_order_no="66" segment_no="23" tag_type="text">On the other hand, tobacco smoke has been suggested to</text>
<text top="662" left="315" width="241" height="9" font="font14" id="p1_t69" reading_order_no="67" segment_no="23" tag_type="text">have an anti-estrogenic and, therefore, anti-carcinogenic<i>Lys751Gln</i></text>
<text top="674" left="315" width="240" height="9" font="font14" id="p1_t70" reading_order_no="68" segment_no="23" tag_type="text">effect [8]. It has also been suggested that the genetic back-</text>
<text top="685" left="315" width="240" height="9" font="font14" id="p1_t71" reading_order_no="69" segment_no="23" tag_type="text">ground might modify the association between tobacco smoke</text>
<text top="697" left="315" width="87" height="9" font="font14" id="p1_t72" reading_order_no="70" segment_no="23" tag_type="text">and breast cancer [4].</text>
<text top="724" left="57" width="472" height="7" font="font3" id="p1_t73" reading_order_no="71" segment_no="26" tag_type="footnote">BER = base excision repair; bp = base pair; CI = confidence interval; NER, nucleotide excision repair; OR = odds ratio; PARP = poly(ADP-<b>Methods</b></text>
<text top="734" left="57" width="466" height="7" font="font3" id="p1_t74" reading_order_no="72" segment_no="26" tag_type="footnote">ribose)polymerase; PCR = polymerase chain reaction; RFLP = restriction fragment length polymorphism; ROS = reactive oxygen species.</text>
</page>
</pdf2xml>
